Literature DB >> 12745197

Heart rate and pulse pressure amplification in hypertensive subjects.

Pierre Laurent1, Pierre Albaladejo, Jacques Blacher, Annie Rudnichi, Harold Smulyan, Michel E Safar.   

Abstract

BACKGROUND: Although mean blood pressure (MBP) remains unmodified along the arterial tree, pulse pressure (PP) increases physiologically from the central to the peripheral arteries. Amplification of PP is known to be influenced by heart rate (HR), but the impact of this alteration has never been tested in patients with hypertension.
METHODS: A total of 712 hypertensive subjects, either treated or untreated, were divided into three classes of HR level. Carotid and brachial systolic blood pressure (SBP), carotid augmentation index, a marker of wave reflections, and carotid-brachial PP amplification were measured using applanation tonometry.
RESULTS: Independent of age, sex, and antihypertensive drugs, subjects with HR >80 beats/min were characterized, in comparison with those with lower HR, by reduced carotid SBP, PP, and augmentation index, resulting in a significant increase in PP amplification. In men but not in women, this pattern was associated with higher values of brachial SBP and DBP and by higher incidences of elevated glycemia and atherosclerotic alterations. In the male population, PP amplifications was, independent of HR, associated with the presence of beta blocking agents (negative association) and elevated plasma glucose.
CONCLUSIONS: Hypertensive men and women with high HR have significant PP amplifications, principally because of reduced central SBP and disturbed wave reflections. beta-blocking agents and plasma glucose independently alter PP amplification in men but not in women. Whether these opposite patterns influence the gender difference in cardiovascular risk should be prospectively studied.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12745197     DOI: 10.1016/s0895-7061(03)00063-3

Source DB:  PubMed          Journal:  Am J Hypertens        ISSN: 0895-7061            Impact factor:   2.689


  10 in total

1.  Comparative effects of ivabradine, a selective heart rate-lowering agent, and propranolol on systemic and cardiac haemodynamics at rest and during exercise.

Authors:  Robinson Joannides; Nicholas Moore; Michaela Iacob; Patricia Compagnon; Guy Lerebours; Jean-François Menard; Christian Thuillez
Journal:  Br J Clin Pharmacol       Date:  2006-02       Impact factor: 4.335

2.  Low night-time heart rate is longitudinally associated with lower augmentation index and central systolic blood pressure in hypertension.

Authors:  Paolo Palatini; Francesca Saladini; Lucio Mos; Claudio Fania; Adriano Mazzer; Edoardo Casiglia
Journal:  Eur J Appl Physiol       Date:  2018-01-02       Impact factor: 3.078

Review 3.  The Role of Central Blood Pressure Monitoring in the Management of Hypertension.

Authors:  Adrian Ochoa; Gabriel Patarroyo-Aponte; Mahboob Rahman
Journal:  Curr Cardiol Rep       Date:  2018-04-19       Impact factor: 2.931

4.  Cyclooxygenase inhibition augments central blood pressure and aortic wave reflection in aging humans.

Authors:  Jill N Barnes; Darren P Casey; Casey N Hines; Wayne T Nicholson; Michael J Joyner
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-04-13       Impact factor: 4.733

5.  Association Between Central-Peripheral Blood Pressure Amplification and Structural and Functional Cardiac Properties in Children, Adolescents, and Adults: Impact of the Amplification Parameter, Recording System and Calibration Scheme.

Authors:  Alejandro Díaz; Daniel Bia
Journal:  High Blood Press Cardiovasc Prev       Date:  2021-02-23

Review 6.  Pulse pressure, heart rate, and drug treatment of hypertension.

Authors:  Michel E Safar
Journal:  Curr Hypertens Rep       Date:  2004-06       Impact factor: 5.369

7.  Heart rate reduction decreases central blood pressure in sick sinus syndrome patients with a permanent cardiac pacemaker.

Authors:  Tuuli Teeäär; Martin Serg; Kaido Paapstel; Jaak Kals; Mart Kals; Mihkel Zilmer; Jaan Eha; Priit Kampus
Journal:  J Hum Hypertens       Date:  2018-03-27       Impact factor: 3.012

8.  Baseline predictors of central aortic blood pressure: a PEAR substudy.

Authors:  Rebecca F Rosenwasser; Niren K Shah; Steven M Smith; Xuerong Wen; Yan Gong; John G Gums; Wilmer W Nichols; Arlene B Chapman; Eric Boerwinkle; Julie Johnson; Benjamin Epstein
Journal:  J Am Soc Hypertens       Date:  2014-01-03

9.  Pulse wave velocity is more closely associated with cardiovascular risk than augmentation index in the relatively low-risk population.

Authors:  Bong Gun Song; Jeong Bae Park; Soo Jin Cho; Sang Yeub Lee; Jung Hyuk Kim; Seung Min Choi; Ji Han Park; Yong Hwan Park; Jin-Oh Choi; Sang-Chol Lee; Seung Woo Park
Journal:  Heart Vessels       Date:  2009-11-22       Impact factor: 2.037

10.  Transcatheter aortic valve replacement (TAVR) leads to an increase in the subendocardial viability ratio assessed by pulse wave analysis.

Authors:  Claudia Müller; Georg Goliasch; Stefan Schachinger; Stefan Kastl; Thomas Neunteufl; Georg Delle-Karth; Johannes Kastner; Mariann Gyöngyösi; Irene Lang; Michael Gottsauner-Wolf; Noemi Pavo
Journal:  PLoS One       Date:  2018-11-21       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.